Disciplines: Respiratory Therapy
Hours: 12 Contact Hours
Item#: VGQID

Six Infectious Diseases that Impact the Respiratory System Bundle


Reg. Prices
Just $59.95
Item # VGQID
When available, the Online Course format is included with the hard copy, eBook, or audio book formats!

This bundle includes six up-to-date courses, each covering one type of communicable disease affecting the respiratory system.  The diseases addressed range from a Class A bioterrorism agent (Anthrax), to a preventable yet re-emerging childhood disease (Pertussis). Respiratory therapists should know the symptoms, treatment, and prevention for each of these diseases. Whether bacterial or viral, they all have one thing in common: they dramatically impact the respiratory system.  

This product includes the following courses:
Click on the title to see more and read the course

Anthrax: A Bioterrorist Weapon, 2nd Edition

Price: $29.95 Hours:3 Contact Hours
Item # V7234  

So far as is known, all primitive and civilized societies have suffered diseases caused by pathogenic microorganisms. Frequently, the results have been disastrous. One of several microbial candidates believed to have great potential as a biological weapon is the bacterium Bacillus anthracis, the cause of the infection anthrax. the threat of bioterrorism has brought anthrax beyond the point of scientific inquiry and has created new challenges for medical and public health professionals. This course presents the currently known properties of Bacillus anthracis and the understanding of the pathogenesis, approaches to diagnosis, prevention and control measures, and treatment of anthrax. Consideration also is given to selected aspects of bioweapons and features of bioterrorism.

AARC Approval #145261000

Avian (H5N1) Influenza, 3rd Edition

Price: $9.95 Hours:1 Contact Hour
Item # V7220  

Influenza is a highly contagious, acute febrile respiratory illness caused by the influenza virus. Epidemic outbreaks of influenza occur every year in the United States and around the world. These outbreaks result in an average of 200,000 hospitalizations and 36,000 deaths each year in the United States (Centers for Disease Control and Prevention [CDC], 2011; Thompson et al., 2010). Most fatal cases of influenza in the United States occur in the very young, the very old, and those whose immune systems are compromised (Thompson et al., 2010). However, influenza viruses can infect people of any age and can infect animals, including birds, pigs, horses, dogs, and marine mammals. Wild birds and domestic poultry are the natural reservoirs for all influenza A subtypes (H1 to H16), although humans are also often infected by subtypes H1 to H3 (CDC, 2013). Influenza subtypes that occur most often in birds are called avian influenza strains. 

Every year, circulating influenza A strains mutate or change. Most strain mutations are relatively minor and are called antigenic drift, meaning that characteristics of the new strain have changed or drifted slightly from the original. Occasionally, however, influenza strains will mutate significantly, resulting in an antigenic shift, meaning that the new strain is significantly different from the original strain. These shifts may mean that humans are now susceptible to avian influenza or that the route of transmission may change, making human-to-human spread easier.

Nurses compose the largest segment of healthcare providers, and are poised to be at the forefront in managing care for patients with avian influenza. In addition, physicians, counselors, respiratory therapists, and other healthcare professionals will be needed to help identify, treat, isolate, and manage patients with avian influenza. It is essential that all healthcare professionals become familiar with the epidemiology, threat, clinical description, infection prevention, and patient management of avian influenza. This information will aid healthcare professionals in rapidly recognizing and responding to outbreaks of avian influenza, which will decrease morbidity, mortality, and costs of the virus.

The purpose of this course is to provide nurses and other healthcare providers with information on the emerging threat, epidemiology, and clinical description of avian influenza. The overall objective of this course is to increase the learner’s knowledge of avian influenza and the response steps they can take to decrease the spread of disease during an avian influenza pandemic.

AARC Course Approval #143587000

H1N1 Flu: Implications for Healthcare Professionals, 3rd Edition

Price: $9.95 Hours:1 Contact Hour
Item # V7219  

In spring 2009, an outbreak of what was thought to be swine flu occurred in Mexico and was soon confirmed in many other countries. Although this illness was first called swine flu, upon further analysis it was determined that the virus’s genetic makeup was a mixture of swine and avian influenza viruses—a new contagious strain of influenza A virus, known as the H1N1 virus. To more accurately denote its type, the U.S. Centers for Disease Control and Prevention (CDC) named it novel influenza A (H1N1) virus. Throughout this course, the pathogen is referred to as the H1N1 virus, and the illness it causes is referred to as the H1N1 flu.

Infection was first reported in humans in Mexico, and federal health officials determined that the virus was contagious and was being transmitted from person to person. In late March and early April 2009, human cases of H1N1 virus infection were identified in California as well as in Texas. Through the spring, the number of reported cases grew each day. The CDC declared a public health emergency in order to mobilize health teams and treatment therapies to needed areas and to initiate containment. The World Health Organization (WHO), which is responsible for maintaining the H1N1 flu case count worldwide, declared this outbreak a global pandemic and advised governments to be prepared for this first 21st-century flu pandemic. By June 2009, all 50 states in the United States, the District of Columbia, Puerto Rico, and the U.S. Virgin Islands had reported novel H1N1 virus cases. There were two distinct patient waves during the 2009–2010 H1N1 pandemic before it officially ended in August 2010. Laboratory testing for H1N1 virus was inaccurate, and the high number of cases coupled with frequent false negatives led U.S. health officials to stop reporting individual cases. Though the mortality rate for H1N1 virus infection was low (<1%), more than 18,000 individuals worldwide died from H1N1 flu during the pandemic, and it is believed that the actual number is significantly higher than that estimate because of a general lack of reporting and inaccurate laboratory testing.

Despite the fact that the H1N1 virus pandemic has ended, H1N1 influenza has become endemic within the United States and around the world. Healthcare professionals and others who may come in contact with infected persons must have basic knowledge and practice competencies that enable them to understand the transmission, symptoms, diagnosis, identification, treatment modalities, and prevention of H1N1 flu in order to help contain an outbreak. This course gives readers essential information regarding the evolution of H1N1 flu so that they can identify potential H1N1 flu cases. This course also describes the virus and its transmission; reviews symptoms that may be exhibited by infected persons; discusses how to screen and protect patients; reviews the methods of case confirmation and outlines how H1N1 flu can be differentiated from other influenzas; reviews treatment, prevention, and control; and describes how readers can protect themselves.

AARC Approval #143429000

Pertussis: Diagnosis, Treatment, and Prevention, 2nd Edition

Price: $29.95 Hours:3 Contact Hours
Item # V7203  

Pertussis, or whooping cough, is a contagious disease that affects the respiratory tract. Historically, the very young who were not immunized against the disease became infected. However, because immunity acquired from vaccination or having the disease wanes over time, there are periodic outbreaks of the disease in infants and young and older adults.

Healthcare professionals have several important roles in caring for a patient with pertussis. In ambulatory care settings, they are often first to detect the disease, and community health nurses and other healthcare professionals provide patient care and support to the family and caregivers during the illness.

Another significant contribution made by healthcare professionals is the education of the public about the need for vaccination of adolescents and adults as well as vaccination of infants and preschoolers. Reducing the disease reservoir by vaccination will reduce pertussis outbreaks and save lives. The purpose of this course is to provide the healthcare professional with an understanding of pertussis, including its incidence, transmission, signs and symptoms, diagnosis, treatment, complications, and prevention. The course is relevant to a broad range of healthcare providers employed in public health agencies, schools, community health clinics, and such institutions as hospitals and long-term care facilities. The references and resources identified throughout the course provide additional information about pertussis.

AARC Approval #143357000

Tuberculosis Across the Lifespan, 2nd Edition

Price: $29.95 Hours:3 Contact Hours
Item # V7148  

Tuberculosis (TB), formerly known as consumption, was a known health issue as far back as ancient Egypt and it continues to be one of the deadliest diseases worldwide. TB has always occurred disproportionately among the poor and disadvantaged populations. In spite of a decline in the total number of cases in the United States in the past decade, 9,588 new cases of TB were reported in 2013.

In addition, the threat of TB infection in healthcare workers is a growing concern. Healthcare professionals have a critical role in the detection and care of people with TB. Accurate and appropriate assessment, along with implementation of a suitable care plan is necessary to prevent transmission of this disease. Research continues to discover ways to improve approaches to TB; however, detection and treatment remain a long and difficult process. This course provides an overview of the current information about TB across the lifespan. Prevention, detection, and treatment options are included, with a focus on measures to protect healthcare workers from contracting TB. The course is intended for healthcare professionals who practice in various settings – from institutional to community-based. Having current knowledge about TB is the only way to provide effective care to this population.

AARC Approval #143104000

West Nile Virus, Updated 5th Edition

Price: $9.95 Hours:1 Contact Hour
Item # V7146  

West Nile virus (WNV) has emerged as a public health threat in North America. While the virus was first isolated in the West Nile District of Uganda in 1937, outbreaks occurred in eastern Europe in the 1990s, with the first appearance in North America in 1999 (CDC, 2011). WNV has since spread rapidly across the continental United States, affecting thousands of humans, horses, and birds. This virus, spread primarily by blood-feeding mosquitoes, can cause severe illness in susceptible humans, animals, and wildlife. 2012 was one of the largest outbreaks of WNV ever seen.

The public looks to healthcare professionals for accurate information and guidance on health-related topics. This course is designed for healthcare professionals in all levels and areas of practice. The purpose of this course is to provide current information and insight about WNV as a foundation for preemptive actions and responses to care for those affected by WNV. In addition, the course will offer insight on ways to help minimize disease transmission to people and animals. This course focuses on the history and emergence of WNV, transmission, clinical symptoms, diagnosis, treatment, and prevention strategies.

AARC Approval #147542000